savepiginvest

savepiginvest

BerGenBio OSL:BGBIO is a norwegian clinical-stage biopharmaceutical company focused on developing transformative drugs targeting AXL as a potential cornerstone of therapy for aggressive diseases, including immune-evasive, therapy resistant cancers. The stock is currently in a short term uptrend that could provide a new test of important resistance, where a...

savepiginvest

www.tradingview.com

savepiginvest

Targovax OSL:TRVX a clinical phase norwegian Biotech is currently at market cap NOK 327 million / 35 million USD. Value inflection point very close as the company will need to raise funds in the very near future, which must either come from investors or from a possible partner deal. PRESENTATION OF ONCOS-102 MELANOMA DATA AT SITC ANNUAL MEETING ...

savepiginvest

Oslo Stock Exchange info page: www.oslobors.no Oslo Cancer Cluster: oslocancercluster.no Radforsk: radforsk.no ------------------------------------------ Photocure IR: OSL:PHO photocure.com Nordic Nanovector IR: OSL:NANO www.nordicnanovector.com PCI Biotech IR: OSL:PCIB pcibiotech.no BergenBio IR: OSL:BGBIO www.bergenbio.com ...

savepiginvest

Recent news by OSL:PHO : Randomized phase 3 study in Denmark demonstrates significant advantage in Bladder Cancer for Hexvix/Cysview blue light cystoscopy over standard white light variant: photocure.com At Q3 2019 Photocure reported continued record growth in the US as well as upfront payments from Chinese partner Asieris: photocure.com Further...

savepiginvest

Photocure OSL:PHO presented Q3 numbers with top line numbers just a hint weaker than consensus, but with the strongest quarterly growth rate in deployed cystoscopes ever noted. The stock is currently trading above earlier support, and a move through NOK 60 could trigger a strong BUY signal. Q3 Report: photocure.com Q3 webcast in english with CEO Daniel...

savepiginvest

The initial rally in OSL:FUNCOM share after news broke that Tencent bought the largest position in the Oslo based gaming company was called off after primary insider Fredrik Malmberg sold a large amount of shares the same day. This is giving the market a chance of buying Funcom stock with a healthy discount compared to the share price payed by Tencent. Funcom...

savepiginvest Updated 

OSL:PHO Company press release about partnership deal URL: twitter.com Edison analyst update URL: www.edisongroup.com

savepiginvest Updated 

PCI Biotech Holding OSL:PCIB stock has been consolidating in a trading range below last years 30 NOK shareprice rights issue of NOK 360 million. Positive market reaction to the latest quarterly report from the company, along with good coverage in magasines: www.tu.no (norwegian language) nordiclifescience.org (page 91-94) At the moment, the stock is...

savepiginvest Updated 

Photocure $PHO.OL OSL:PHO presented Q2 2019 numbers today, with most numbers landing very close to expectations. Webcast: webtv.hegnar.no Press release: newsweb.oslobors.no Armchair Healthcare podcast interview with CEO Dan Schneider: twitter.com

savepiginvest

Investors are eagerly awaiting Photocures OSL:PHO Q2 2019 report to get a more indepth description of the recently announced Cevira partnership deal. Also key is the information about the current growth rate on Cysview sales in US. NOK 60-64 is a key level of expected resistance, as it is where the share price peaked in 2018, while a negative reaction could...

savepiginvest

Photocure OSL:PHO today released news of a outlicensing of the Cevira franchise for commercialization, giving the stock a boost, possibly regaining foothold above the SMA50 and SMA200. Press release photocure.com

savepiginvest

OSL:PCIB www.netfonds.no Oslo (Norway), 2 May 2019 . PCI Biotech ( OSL:PCIB ), a cancer focused clinical-stage company developing innovative therapeutics that address significant unmet medical needs today announced that the final immune response results from the fima_Vacc_ Phase I study in healthy volunteers indicate a clear enhancement of both CD8 and CD4...

savepiginvest Updated 

In January, NEL Hydrogen finished a very successful large private offering at NOK 5.45 ( nelhydrogen.com ) , but both the technical uptrend and fundamentals remain solid, with the company set to invest the proceeds from the placement in rapidly scaling up production facilities. Company twitter feed for news: twitter.com

savepiginvest Updated 

Photocure $PHO.OL approaching relevant resistance levels and a breakout to the upside could easily be triggered as the market cap of the company is still low. Recent Edison analysis quote: " Phenomenal US growth Q418 sales in the US increased 81% to NOK18.4m and are up 50% over the course of 2018 with a clear acceleration in the second half of the year. Unit...

savepiginvest

Photocure $PHO.OL stock reacted with a correction after a overblown rally ahead of Q4 2018 report, but found firm footing and looks set to restart positive trend.

savepiginvest Updated 

As mentioned in an earlier Idea ( ), the Q4 report represented a substantial risk for a downwards reaction after a recent surge in the share price. At the new price level around NOK 41 the stock is much more attractively priced, and this could be the time to move in for new investors.

savepiginvest Updated 

BUY Signal: Any move on high volume punching through NOK 15 and especially NOK 16.5 represents renewed positive momentum in the FUNCOM stock. --------------------------------------------------------------------- The top 20 owner list in Funcom has been dominated by active traders selling off after the recent NOK 25 peak that occured after Funcom announced that...